New Strategies for Multiple Myeloma Care: Next Steps for the Future

In this comprehensive set of text modules 5 international myeloma experts explore the latest clinical developments for managing patients with myeloma. Topics covered include diagnosis and risk stratification of plasma cell disorders management of newly diagnosed MM treatment of relapsed/refractory disease and promising novel agents.

Share

Supporters

This activity is supported by educational grants from

AbbVie

Amgen, Inc.

Bristol Myers Squibb

Celgene

Janssen administered by Scientific Affairs

Takeda Oncology

Partners

IMF 2018

ProCE Banner